Cantor Fitzgerald Issues Positive Outlook for DNTH Earnings
Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Analysts at Cantor Fitzgerald increased their FY2025 earnings per share (EPS) estimates for shares of Dianthus Therapeutics in a research note issued to investors on Thursday, March 13th. Cantor Fitzgerald analyst P. Stavropoulos now expects that the company will earn ($3.16) per share for the year, up […]
19 Mar 06:05 · The Markets Daily